Material Insights · Understanding the Material World

GLP-1 receptor agonists: Materials

Materials it needs

The commodities and chemicals it needs per unit, its share of each one's demand and how critical each is

Made of Uses Needs
  • Qz Silica sand criticality low The medicine is held in glass cartridges or vials, and glass is made mainly from silica sand.

as of 2026-11-11. No source gives material amounts per dose; criticality is the writer's judgement. Peptides rank medium because supply is tight: WHO says that even with rapid expansion in production, the medicines are projected to reach fewer than 10% of those who could benefit by 2030 [3].

Critical materials

The materials whose supply could hold it back

  • No scarce raw material holds these medicines back: amino acids and excipients are made in large amounts for other uses.
  • Supply falls far short of need: even with rapid expansion in production, WHO projects the medicines will reach fewer than 10% of those who could benefit by 2030, and it calls for action on manufacturing and affordability [3].
  • Supply is concentrated in a few companies; Novo Nordisk says it holds 45.8% of the GLP-1 diabetes market by value [5].

as of 2026-11-11

Sources

  1. GLP-1-based therapy for obesity Lasker Foundation (2024 Lasker~DeBakey Clinical Medical Research Award), 2024
  2. WHO issues global guideline on the use of GLP-1 medicines in treating obesity World Health Organization, 2025
  3. Financial report for the period 1 January 2025 to 31 December 2025 (company announcement No 4/2026, Form 6-K) Novo Nordisk A/S, filed with the US Securities and Exchange Commission, 2026